首页> 外文会议>International Molecular Medicine Tri-Conference. >Histopathological Image Analysis for Necroptosis Biomarkers Research
【24h】

Histopathological Image Analysis for Necroptosis Biomarkers Research

机译:虐疮生物标志物研究的组织病理学图像分析

获取原文

摘要

Necroptosis is a caspase independent programmed cell death similar to necrosis. It also exhibits cell swelling and rupture of the cellular membrane and hence it can promote an inflammatory response. Recent studies have linked necroptosis to immune inflammatory diseases such as psoriasis and IBD and several 'necroptosis inhibitors' are currently being studied in clinical trials for their potential to treat these diseases. Among the most studied necroptosis key players are Caspase-8, RIP1, RIP3 and MLKL. During Caspase-8 inactivation, RIPK1 recruits RIPK3 forming the necrosome which autophosphorylates and then recruits and activates MLKL. Finally MLKL translocates to the cell membrane increasing its permeability and ultimately causing cell death. In this work, we present our current approaches to study necroptosis biomarkers through digital pathology. We tuned image analysis algorithms to study total or activated forms of Caspase-8, RIP1, RIP3 and MLKL in skin and colon biopsies. We will also discuss some image analysis validation guidelines followed in the GSK Histo Hub. Because necroptosis has also been implicated in neurodegenerative diseases such as ALS, Alzheimer, Parkinson and immunotherapy resistance in cancer, we will introduce the early development of multiplexing and algorithm calibration studies to identify necroptotic and immune cell populations in nervous tissue and tumors.
机译:Necroptis是一种与坏死类似的Caspase独立编程的细胞死亡。它还表现出细胞膜的细胞溶胀和破裂,因此它可以促进炎症反应。最近的研究与免疫炎症性疾病联系起来,如牛皮癣和IBD,目前正在研究临床试验中的几个“肮脏抑制剂”,以潜力治疗这些疾病。在最多研究的肮脏术钥匙球员中是Caspase-8,RIP1,RIP3和MLKL。在Caspase-8失活期间,RIPK1 recuity Ripk3形成尸体体,其自磷酸盐酸盐,然后再发电并激活MLK1。最后MLKL转向细胞膜,增加其渗透性并最终导致细胞死亡。在这项工作中,我们展示了目前通过数字病理学研究死亡生物标志物的目前的方法。我们调整图像分析算法以研究皮肤和结肠活组织检查中的Caspase-8,RIP1,RIP3和MLK1的总体或活化形式。我们还将讨论GSK Histo集线器中的一些图像分析验证指南。由于肮脏的症也涉及癌症,阿尔茨海默,帕金森和免疫治疗抗药性疾病的神经变性疾病,我们将介绍多路复用和算法校准研究的早期发展,以识别神经组织和肿瘤中的坏死和免疫细胞群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号